BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

Clinical trial NCT01156311 · COMPLETED

Trial details

NCT number: NCT01156311
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis Multiple Sclerosis

Start date: 2010-06-01
Primary completion: 2012-03-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.